Biotech gains amid buyout chatter, upbeat clinical trial results
August 24, 2016 at 12:48 PM EDT
Buyout chatter and optimistic trial results boosted the biotechnology sector on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.